{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:04Z","timestamp":1790985604360,"version":"4.1.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":3558,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.3945\/an.111.001693","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T09:51:47Z","timestamp":1343209907000},"page":"257-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["(N-3) Fatty Acids: Molecular Role and Clinical Uses in Psychiatric Disorders"],"prefix":"10.1016","volume":"3","author":[{"given":"Pedro Luis","family":"Prior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos Fernandes","family":"Galdur\u00f3z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.3945\/an.111.001693_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1740-8709.2011.00302.x","article-title":"Food sources and intake of n-6 and n-3 fatty acids in low-income countries with emphasis on infants, young children (6\u201324 months), and pregnant and lactating women","volume":"7","author":"Michaelsen","year":"2011","journal-title":"Matern Child Nutr"},{"key":"10.3945\/an.111.001693_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000329300","article-title":"Early impact of prescription omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia","volume":"118","author":"Serebruany","year":"2011","journal-title":"Cardiology"},{"key":"10.3945\/an.111.001693_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1753-4887.2010.00287.x","article-title":"Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids","volume":"68","author":"Wall","year":"2010","journal-title":"Nutr Rev"},{"key":"10.3945\/an.111.001693_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.plefa.2010.02.023","article-title":"Polyunsaturated fatty acids in the modulation of T-cell signalling","volume":"82","author":"Akhtar Khan","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.111.001693_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S1464793104006578","article-title":"Dietary fats and membrane function: implications for metabolism and disease","volume":"80","author":"Hulbert","year":"2005","journal-title":"Biol Rev Camb Philos Soc"},{"key":"10.3945\/an.111.001693_bib6","first-page":"608","article-title":"Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care","volume":"166","author":"Holub","year":"2002","journal-title":"CMAJ"},{"key":"10.3945\/an.111.001693_bib7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3945\/ajcn.110.007377","article-title":"N-3 PUFAs in cancer, surgery, and critical care: a systematic review on clinical effects, incorporation, and washout of oral or enteral compared with parenteral supplementation","volume":"94","author":"van der Meij","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.111.001693_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.108.771881","article-title":"Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women","volume":"118","author":"Heidemann","year":"2008","journal-title":"Circulation"},{"key":"10.3945\/an.111.001693_bib9","first-page":"205","article-title":"Clinical nutrition: 3. The fuzzy boundary between nutrition and psychopharmacology","volume":"166","author":"Young","year":"2002","journal-title":"CMAJ"},{"key":"10.3945\/an.111.001693_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1749-6632.1989.tb53234.x","article-title":"Nutrient imbalances in depressive disorders. Possible brain mechanisms","volume":"575","author":"Wurtman","year":"1989","journal-title":"Ann N Y Acad Sci"},{"key":"10.3945\/an.111.001693_bib11","first-page":"80","article-title":"Folate and depression\u2013a neglected problem","volume":"32","author":"Young","year":"2007","journal-title":"J Psychiatry Neurosci"},{"key":"10.3945\/an.111.001693_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(05)79168-6","article-title":"Fish consumption and major depression","volume":"351","author":"Hibbeln","year":"1998","journal-title":"Lancet"},{"key":"10.3945\/an.111.001693_bib13","first-page":"837","article-title":"The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: substrate pellagra","volume":"16","author":"Rudin","year":"1981","journal-title":"Biol Psychiatry"},{"key":"10.3945\/an.111.001693_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0306-9877(82)90088-3","article-title":"The dominant diseases of modernized societies as omega-3 essential fatty acid deficiency syndrome: substrate beriberi","volume":"8","author":"Rudin","year":"1982","journal-title":"Med Hypotheses"},{"key":"10.3945\/an.111.001693_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000419283","article-title":"Essentiality of omega 3 fatty acids for brain structure and function","volume":"66","author":"Bourre","year":"1991","journal-title":"World Rev Nutr Diet"},{"key":"10.3945\/an.111.001693_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/(SICI)1097-4547(19990615)56:6<565::AID-JNR2>3.0.CO;2-H","article-title":"Essential fatty acids are mediators of brain biochemistry and cognitive functions","volume":"56","author":"Yehuda","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.3945\/an.111.001693_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0305-0491(97)00357-X","article-title":"The proton permeability of the inner membrane of liver mitochondria from ectothermic and endothermic vertebrates and from obese rats: correlations with standard metabolic rate and phospholipid fatty acid composition","volume":"119","author":"Brookes","year":"1998","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"10.3945\/an.111.001693_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00114-003-0470-z","article-title":"Docosahexaenoic acid (DHA) content of membranes determines molecular activity of the sodium pump: implications for disease states and metabolism","volume":"90","author":"Turner","year":"2003","journal-title":"Naturwissenschaften"},{"key":"10.3945\/an.111.001693_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s003600050224","article-title":"What role for membranes in determining the higher sodium pump molecular activity of mammals compared to ectotherms?","volume":"169","author":"Else","year":"1999","journal-title":"J Comp Physiol B"},{"key":"10.3945\/an.111.001693_bib20","doi-asserted-by":"crossref","first-page":"R633","DOI":"10.1152\/ajpregu.00549.2003","article-title":"Membrane lipids and sodium pumps of cattle and crocodiles: an experimental test of the membrane pacemaker theory of metabolism","volume":"287","author":"Wu","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"Suppl","key":"10.3945\/an.111.001693_bib21","first-page":"S107","article-title":"The electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of n-3 polyunsaturated fatty acids: heart and brain","volume":"36","author":"Leaf","year":"2001","journal-title":"Lipids"},{"key":"10.3945\/an.111.001693_bib22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MCO.0b013e32834fdaf7","article-title":"Update on lipids and mitochondrial function: impact of dietary n-3 polyunsaturated fatty acids","volume":"15","author":"Stanley","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.3945\/an.111.001693_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(03)00101-4","article-title":"Docosahexaenoic acid: membrane properties of a unique fatty acid","volume":"126","author":"Stillwell","year":"2003","journal-title":"Chem Phys Lipids"},{"key":"10.3945\/an.111.001693_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11745-997-0064-6","article-title":"Effect of docosahexaenoic acid on mouse mitochondrial membrane properties","volume":"32","author":"Stillwell","year":"1997","journal-title":"Lipids"},{"key":"10.3945\/an.111.001693_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1476-511X-10-142","article-title":"On the protective effect of omega-3 against propionic acid-induced neurotoxicity in rat pups","volume":"10","author":"El-Ansary","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.3945\/an.111.001693_bib26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.pharmtox.48.121506.124841","article-title":"Caveolae as organizers of pharmacologically relevant signal transduction molecules","volume":"48","author":"Patel","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.3945\/an.111.001693_bib27","doi-asserted-by":"crossref","first-page":"34614","DOI":"10.1074\/jbc.M404673200","article-title":"Caveolin-1 interacts with 5\u2013HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors","volume":"279","author":"Bhatnagar","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3945\/an.111.001693_bib28","doi-asserted-by":"crossref","first-page":"9941","DOI":"10.1523\/JNEUROSCI.1647-07.2007","article-title":"Caveolin proteins are essential for distinct effects of membrane estrogen receptors in neurons","volume":"27","author":"Boulware","year":"2007","journal-title":"J Neurosci"},{"key":"10.3945\/an.111.001693_bib29","first-page":"321","article-title":"Nuclear receptor coregulators: cellular and molecular biology","volume":"20","author":"McKenna","year":"1999","journal-title":"Endocr Rev"},{"key":"10.3945\/an.111.001693_bib30","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1096\/fj.07-9299com","article-title":"Caveolin-1 expression is essential for N-methyl-D-aspartate receptor-mediated Src and extracellular signal-regulated kinase 1\/2 activation and protection of primary neurons from ischemic cell death","volume":"22","author":"Head","year":"2008","journal-title":"FASEB J"},{"key":"10.3945\/an.111.001693_bib31","doi-asserted-by":"crossref","first-page":"30429","DOI":"10.1074\/jbc.272.48.30429","article-title":"Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine\/threonine kinase activities","volume":"272","author":"Couet","year":"1997","journal-title":"J Biol Chem"},{"key":"10.3945\/an.111.001693_bib32","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1124\/mol.107.034769","article-title":"Regulation of D1 dopamine receptor trafficking and signaling by caveolin-1","volume":"72","author":"Kong","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.3945\/an.111.001693_bib33","first-page":"313","article-title":"Fatty acids, cytokines, and major depression","volume":"43","author":"Maes","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.3945\/an.111.001693_bib34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/01.PSY.0000035719.79068.2B","article-title":"The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men","volume":"65","author":"Suarez","year":"2003","journal-title":"Psychosom Med"},{"key":"10.3945\/an.111.001693_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0162-3109(96)00111-7","article-title":"Tricyclic antidepressants inhibit IL-6, IL-1, and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells","volume":"34","author":"Xia","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.3945\/an.111.001693_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0049-0172(97)80009-1","article-title":"Dietary n-3 fatty acids and therapy for rheumatoid arthritis","volume":"27","author":"James","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.3945\/an.111.001693_bib37","doi-asserted-by":"crossref","first-page":"343S","DOI":"10.1093\/ajcn\/71.1.343S","article-title":"Dietary polyunsaturated fatty acids and inflammatory mediator production","volume":"71","author":"James","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.111.001693_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1271\/bbb.61.763","article-title":"Effect of dietary n-3\/n-6 fatty acid ratio on the total count, fatty acid composition, and histamine and leukotriene concentrations of mast cells in tunica mucosa bronchiorum of type I allergic guinea pig","volume":"61","author":"Kuwamori","year":"1997","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.3945\/an.111.001693_bib39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0262-1746(83)90048-3","article-title":"Elevated levels of prostaglandin E2 and thromboxane B2 in depression","volume":"10","author":"Lieb","year":"1983","journal-title":"Prostaglandins Leukot Med"},{"key":"10.3945\/an.111.001693_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-3223(03)00181-1","article-title":"Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants","volume":"54","author":"Shimizu","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.3945\/an.111.001693_bib41","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0896-6273(00)80654-6","article-title":"An essential role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression","volume":"21","author":"Chiang","year":"1998","journal-title":"Neuron"},{"key":"10.3945\/an.111.001693_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.mp.4001888","article-title":"N-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism","volume":"12","author":"Rao","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.3945\/an.111.001693_bib43","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jnr.22390","article-title":"Omega3 fatty acids reverse age related decreases in nuclear receptors and increase neurogenesis in old rats","volume":"88","author":"Dyall","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.3945\/an.111.001693_bib44","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neuroscience.2006.01.021","article-title":"Docosahexaenoic acid promotes neurogenesis in vitro and in vivo","volume":"139","author":"Kawakita","year":"2006","journal-title":"Neuroscience"},{"key":"10.3945\/an.111.001693_bib45","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1471-4159.2012.07660.x","article-title":"Saturated long-chain fatty acids activate inflammatory signaling in astrocytes","volume":"120","author":"Gupta","year":"2012","journal-title":"J Neurochem"},{"issue":"Suppl 1","key":"10.3945\/an.111.001693_bib46","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.ejphar.2011.05.085","article-title":"Fatty acids and inflammation: the cutting edge between food and pharma","volume":"668","author":"Calder","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.3945\/an.111.001693_bib47","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s11064-011-0471-9","article-title":"Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains","volume":"36","author":"Mythri","year":"2011","journal-title":"Neurochem Res"},{"key":"10.3945\/an.111.001693_bib48","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4088\/JCP.11ac06830","article-title":"Omega-3 fatty acids and depression: from cellular mechanisms to clinical care","volume":"72","author":"Freeman","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.3945\/an.111.001693_bib49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/PSY.0b013e3180313a45","article-title":"Depressive symptoms, n-6:n-3 fatty acids, and inflammation in older adults","volume":"69","author":"Kiecolt-Glaser","year":"2007","journal-title":"Psychosom Med"},{"key":"10.3945\/an.111.001693_bib50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0165-1781(99)00014-1","article-title":"Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients","volume":"85","author":"Maes","year":"1999","journal-title":"Psychiatry Res"},{"key":"10.3945\/an.111.001693_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0006-3223(97)00206-0","article-title":"Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients","volume":"43","author":"Peet","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.3945\/an.111.001693_bib52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.3945\/an.111.001693_bib53","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00048670701827275","article-title":"Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder","volume":"42","author":"Jazayeri","year":"2008","journal-title":"Aust N Z J Psychiatry"},{"key":"10.3945\/an.111.001693_bib54","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.3945\/an.111.001693_bib55","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0924-977X(03)00032-4","article-title":"Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial","volume":"13","author":"Su","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.3945\/an.111.001693_bib56","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.euroneuro.2008.04.011","article-title":"A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder","volume":"18","author":"Mischoulon","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.3945\/an.111.001693_bib57","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.4088\/JCP.10m05966blu","article-title":"The efficacy of omega-3 supplementation for major depression: a randomized controlled trial","volume":"72","author":"Lesp\u00e9rance","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.3945\/an.111.001693_bib58","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1176\/ajp.2006.163.6.1098","article-title":"Omega-3 treatment of childhood depression: a controlled, double-blind pilot study","volume":"163","author":"Nemets","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.3945\/an.111.001693_bib59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","article-title":"Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation","volume":"111","author":"da Silva","year":"2008","journal-title":"J Affect Disord"},{"key":"10.3945\/an.111.001693_bib60","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/gme.0b013e3181f2ea2e","article-title":"Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial","volume":"18","author":"Freeman","year":"2011","journal-title":"Menopause"},{"key":"10.3945\/an.111.001693_bib61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/07315724.2010.10719817","article-title":"Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial","volume":"29","author":"Rondanelli","year":"2010","journal-title":"J Am Coll Nutr"},{"key":"10.3945\/an.111.001693_bib62","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1176\/appi.ajp.160.5.996","article-title":"A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression","volume":"160","author":"Marangell","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.3945\/an.111.001693_bib63","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S0007114507801097","article-title":"No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial","volume":"99","author":"Rogers","year":"2008","journal-title":"Br J Nutr"},{"key":"10.3945\/an.111.001693_bib64","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4088\/JCP.08m04603","article-title":"Double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder","volume":"70","author":"Mischoulon","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.3945\/an.111.001693_bib65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0447.2005.00660.x","article-title":"Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression","volume":"113","author":"Freeman","year":"2006","journal-title":"Acta Psychiatr Scand"},{"key":"10.3945\/an.111.001693_bib66","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4088\/JCP.v69n0418","article-title":"Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Su","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.3945\/an.111.001693_bib67","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.2010.1507","article-title":"Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial","volume":"304","author":"Makrides","year":"2010","journal-title":"JAMA"},{"key":"10.3945\/an.111.001693_bib68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pnpbp.2008.10.003","article-title":"Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample","volume":"33","author":"Doornbos","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3945\/an.111.001693_bib69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/00048670701827267","article-title":"Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial","volume":"42","author":"Rees","year":"2008","journal-title":"Aust N Z J Psychiatry"},{"key":"10.3945\/an.111.001693_bib70","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1067\/mob.2003.275","article-title":"Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing","volume":"188","author":"Llorente","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.3945\/an.111.001693_bib71","first-page":"57","article-title":"The role of omega-3 fatty acids in mood disorders","volume":"9","author":"Stahl","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"10.3945\/an.111.001693_bib72","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1176\/appi.ajp.160.12.2222","article-title":"Cross-national comparisons of seafood consumption and rates of bipolar disorders","volume":"160","author":"Noaghiul","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.3945\/an.111.001693_bib73","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/PSY.0b013e31815aaa42","article-title":"High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism","volume":"69","author":"Conklin","year":"2007","journal-title":"Psychosom Med"},{"key":"10.3945\/an.111.001693_bib74","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/ajcn\/87.5.1156","article-title":"Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study","volume":"87","author":"F\u00e9art","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.111.001693_bib75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1054\/plef.2002.0435","article-title":"Depression and adipose essential polyunsaturated fatty acids","volume":"67","author":"Mamalakis","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.111.001693_bib76","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1399-5618.2010.00799.x","article-title":"Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder","volume":"12","author":"Gracious","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.3945\/an.111.001693_bib77","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ejcn.2008.81","article-title":"Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation","volume":"63","author":"Clayton","year":"2009","journal-title":"Eur J Clin Nutr"},{"key":"10.3945\/an.111.001693_bib78","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.euroneuro.2006.11.006","article-title":"Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial","volume":"17","author":"Wozniak","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.3945\/an.111.001693_bib79","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.plefa.2006.07.008","article-title":"Omega-3 fatty acids in bipolar disorder: clinical and research considerations","volume":"75","author":"Marangell","year":"2006","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.111.001693_bib80","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.188.1.46","article-title":"Efficacy of ethyl eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study","volume":"188","author":"Frangou","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.3945\/an.111.001693_bib81","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0269881106067787","article-title":"Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder","volume":"21","author":"Frangou","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.3945\/an.111.001693_bib82","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.4088\/JCP.v66n1219b","article-title":"Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder","volume":"66","author":"Chiu","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.3945\/an.111.001693_bib83","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4088\/JCP.v66n0608","article-title":"Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study","volume":"66","author":"Osher","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.3945\/an.111.001693_bib84","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial","volume":"56","author":"Stoll","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.3945\/an.111.001693_bib85","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.biopsych.2006.03.056","article-title":"Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder","volume":"60","author":"Keck","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.3945\/an.111.001693_bib86","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ajcn\/88.3.714","article-title":"Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk","volume":"88","author":"Samieri","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.111.001693_bib87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1054\/plef.2002.0408","article-title":"Long-term potentiation in aged rats is restored when the age-related decrease in polyunsaturated fatty acid concentration is reversed","volume":"67","author":"Martin","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.111.001693_bib88","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1523\/JNEUROSCI.4225-04.2005","article-title":"A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model","volume":"25","author":"Lim","year":"2005","journal-title":"J Neurosci"},{"key":"10.3945\/an.111.001693_bib89","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1523\/JNEUROSCI.0055-07.2007","article-title":"Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels","volume":"27","author":"Green","year":"2007","journal-title":"J Neurosci"},{"key":"10.3945\/an.111.001693_bib90","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.01.013","article-title":"MIDAS Investigators. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline","volume":"6","author":"Yurko-Mauro","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3945\/an.111.001693_bib91","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neures.2006.06.010","article-title":"Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction","volume":"56","author":"Kotani","year":"2006","journal-title":"Neurosci Res"},{"key":"10.3945\/an.111.001693_bib92","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA"},{"key":"10.3945\/an.111.001693_bib93","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000218081","article-title":"Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study","volume":"27","author":"Freund-Levi","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3945\/an.111.001693_bib94","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1212\/01.wnl.0000324268.45138.86","article-title":"Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial","volume":"71","author":"van de Rest","year":"2008","journal-title":"Neurology"},{"key":"10.3945\/an.111.001693_bib95","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.plefa.2004.07.001","article-title":"Ethyl-EPA in Alzheimer\u2019s disease\u2013a pilot study","volume":"71","author":"Boston","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.111.001693_bib96","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.pnpbp.2008.05.015","article-title":"The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study","volume":"32","author":"Chiu","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3945\/an.111.001693_bib97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/gps.1857","article-title":"Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms","volume":"23","author":"Freund-Levi","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3945\/an.111.001693_bib98","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","article-title":"Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial","volume":"63","author":"Freund-Levi","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3945\/an.111.001693_bib99","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/000992288702600805","article-title":"Clinical characteristics and serum essential fatty acid levels in hyperactive children","volume":"26","author":"Mitchell","year":"1987","journal-title":"Clin Pediatr (Phila)"},{"key":"10.3945\/an.111.001693_bib100","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/ajcn\/62.4.761","article-title":"Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder","volume":"62","author":"Stevens","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.111.001693_bib101","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jnutbio.2004.01.008","article-title":"Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan","volume":"15","author":"Chen","year":"2004","journal-title":"J Nutr Biochem"},{"key":"10.3945\/an.111.001693_bib102","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0031-9384(95)02207-4","article-title":"Omega-3 fatty acids in boys with behavior, learning, and health problems","volume":"59","author":"Stevens","year":"1996","journal-title":"Physiol Behav"},{"key":"10.3945\/an.111.001693_bib103","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/10284150310001612203","article-title":"Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder","volume":"6","author":"Ross","year":"2003","journal-title":"Nutr Neurosci"},{"key":"10.3945\/an.111.001693_bib104","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1051\/rnd:2005045","article-title":"Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder","volume":"45","author":"Young","year":"2005","journal-title":"Reprod Nutr Dev"},{"key":"10.3945\/an.111.001693_bib105","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/j.1651-2227.2010.01871.x","article-title":"EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD","volume":"99","author":"Gustafsson","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.3945\/an.111.001693_bib106","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/ajcn\/87.5.1170","article-title":"Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids","volume":"87","author":"Vaisman","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.111.001693_bib107","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/1087054708316261","article-title":"Omega-3\/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents","volume":"12","author":"Johnson","year":"2009","journal-title":"J Atten Disord"},{"key":"10.3945\/an.111.001693_bib108","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.ejcn.1601830","article-title":"Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit\/hyperactivity disorder - a placebo-controlled double-blind study","volume":"58","author":"Hirayama","year":"2004","journal-title":"Eur J Clin Nutr"},{"key":"10.3945\/an.111.001693_bib109","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mpd.2001.116050","article-title":"A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit\/hyperactivity disorder","volume":"139","author":"Voigt","year":"2001","journal-title":"J Pediatr"},{"key":"10.3945\/an.111.001693_bib110","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1176\/ajp.161.10.1922","article-title":"Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder","volume":"161","author":"Hirashima","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.3945\/an.111.001693_bib111","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1046\/j.1471-4159.1997.69051850.x","article-title":"The role of glutathione in dopaminergic neuronal survival","volume":"69","author":"Nakamura","year":"1997","journal-title":"J Neurochem"},{"key":"10.3945\/an.111.001693_bib112","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.pscychresns.2009.12.003","article-title":"Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study","volume":"182","author":"Wood","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.3945\/an.111.001693_bib113","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.4088\/JCP.v68n1206","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial","volume":"68","author":"Berger","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.3945\/an.111.001693_bib114","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/sj.npp.1301628","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study","volume":"33","author":"Berger","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.3945\/an.111.001693_bib115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial","volume":"67","author":"Amminger","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.3945\/an.111.001693_bib116","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1176\/appi.ajp.159.9.1596","article-title":"Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia","volume":"159","author":"Emsley","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.3945\/an.111.001693_bib117","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3956(01)00048-6","article-title":"E-E Multicentre Study Group. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms","volume":"36","author":"Peet","year":"2002","journal-title":"J Psychiatr Res"},{"key":"10.3945\/an.111.001693_bib118","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0920-9964(00)00083-9","article-title":"Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia","volume":"49","author":"Peet","year":"2001","journal-title":"Schizophr Res"},{"key":"10.3945\/an.111.001693_bib119","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1176\/appi.ajp.158.12.2071","article-title":"A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia","volume":"158","author":"Fenton","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.3945\/an.111.001693_bib120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0883073807302611","article-title":"Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability","volume":"22","author":"Chez","year":"2007","journal-title":"J Child Neurol"},{"key":"10.3945\/an.111.001693_bib121","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pediatrneurol.2006.11.004","article-title":"Children with autism: effect of iron supplementation on sleep and ferritin","volume":"36","author":"Dosman","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.3945\/an.111.001693_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00787-007-0620-5","article-title":"Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial","volume":"17","author":"Miral","year":"2008","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.3945\/an.111.001693_bib123","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.biopsych.2006.05.007","article-title":"Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study","volume":"61","author":"Amminger","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.3945\/an.111.001693_bib124","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10803-010-1078-8","article-title":"A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder","volume":"41","author":"Bent","year":"2011","journal-title":"J Autism Dev Disord"},{"key":"10.3945\/an.111.001693_bib125","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.arcmed.2008.06.005","article-title":"Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study","volume":"39","author":"Politi","year":"2008","journal-title":"Arch Med Res"},{"key":"10.3945\/an.111.001693_bib126","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jn\/125.4.901","article-title":"Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids","volume":"125","author":"Holman","year":"1995","journal-title":"J Nutr"},{"key":"10.3945\/an.111.001693_bib127","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/ajcn\/41.5.1054","article-title":"Vitamin E, vitamin A and essential fatty acid status of patients hospitalized for anorexia nervosa","volume":"41","author":"Langan","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.111.001693_bib128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.plefa.2004.03.007","article-title":"A pilot open case series of ethyl-EPA supplementation in the treatment of anorexia nervosa","volume":"71","author":"Ayton","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.111.001693_bib129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/eat.10235","article-title":"Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa","volume":"35","author":"Barbarich","year":"2004","journal-title":"Int J Eat Disord"},{"key":"10.3945\/an.111.001693_bib130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3956(03)00077-3","article-title":"A placebo-controlled cross-over trial of adjunctive EPA in OCD","volume":"38","author":"Fux","year":"2004","journal-title":"J Psychiatr Res"},{"key":"10.3945\/an.111.001693_bib131","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI118507","article-title":"The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study","volume":"97","author":"Hamazaki","year":"1996","journal-title":"J Clin Invest"},{"key":"10.3945\/an.111.001693_bib132","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/appi.ajp.160.1.167","article-title":"Omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study","volume":"160","author":"Zanarini","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.3945\/an.111.001693_bib133","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1194\/jlr.M300217-JLR200","article-title":"Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta\u2013induced anxiety, stress, and inflammatory response in rats","volume":"44","author":"Song","year":"2003","journal-title":"J Lipid Res"},{"key":"10.3945\/an.111.001693_bib134","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/10253890410001667188","article-title":"Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1\u2013induced changes in behavior, corticosterone and immune response in rats","volume":"7","author":"Song","year":"2004","journal-title":"Stress"},{"key":"10.3945\/an.111.001693_bib135","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.jcp.0000246214.49271.f1","article-title":"n-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers","volume":"26","author":"Buydens-Branchey","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.3945\/an.111.001693_bib136","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.pnpbp.2007.10.020","article-title":"Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers","volume":"32","author":"Buydens-Branchey","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322009954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322009954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/advances\/article-pdf\/3\/3\/257\/23735404\/257.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T10:33:16Z","timestamp":1743849196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2161831322009954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":136,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S2161831322009954"],"URL":"https:\/\/doi.org\/10.3945\/an.111.001693","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"(N-3) Fatty Acids: Molecular Role and Clinical Uses in Psychiatric Disorders","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/an.111.001693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 American Society for Nutrition","name":"copyright","label":"Copyright"}]}}